C-C and C-S bonds are valuable in organic transformation for synthesizing various bioactive heterocycles. Increasing awareness of the step and atom economy for the reaction, organic chemists have promulgated the...
The quinazolinone template offers an exciting potential
for transforming
molecules into useful bioactivity. Herein, we report the first regioselective
C–5 alkenylation of quinazolinone-coumarin conjugates via ruthenium(II)
catalyst using amide as a weak directing group. This methodology permits
excellent regioselectivity, extensive substrate tolerance, and mild
reaction conditions. In addition, it generates interesting fluorophores
that show positive solvatochromism in the range from 404 nm (toluene)
to 541 nm (methanol).
Palladium‐catalyzed [4+2] oxidative annulation of coumarin‐benzimidazoles with olefins for the synthesis of polycyclic aromatic hydrocarbons have been achieved. This synthetic protocol gives access to a wide range of structurally distinct imidazo[1,2‐a]chromeno[3,4‐c]pyridines in moderate to good yield with wide functional group tolerance. Further, photophysical properties of annulated scaffolds have been examined, which discloses their interesting solvatochromic emission behaviors.
Herein, one-pot cascade synthesis of chromeno[4,3-c]pyrazol-4-ones and their Ru(II)-catalyzed regioselective
ortho-alkenylation
using imine as a weak directing group are done with moderate to good
yields. The reaction proceeds through a three-step domino process
during which intermediates are also isolated in excellent yields.
In addition, this methodology generates a number of interesting fluorophores
with donor and acceptor groups, which show positive solvatochromism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.